Clinical Trial Update: Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (EQUIGEN Single-Dose Study) evaluates the bioequivalence of generic and brand antiepileptic drugs in people with epilepsy using a singl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: University of Cincinnati | Conditions: Epilepsy | Phase 4 | Status: COMPLETED